Data from 10 trials were used. The interventions were found to reduce progression to diabetes, while they were found to have no significant effect on all-cause mortality, cardiovascular mortality, and myocardial infarction, and a marginally statistically significant reduction in risk for stroke. In conclusion, Dr. Ingrid K. Hopper noted that there appears to be no major benefit in cardiovascular outcomes in intervening to prevent diabetes in those with impaired glucose tolerance, hence, interventions should focus less on blood glucose control and more on other efforts. scientificsessions.americanheart.org
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.